Follow US:
NIH grant of $2.2 million could help researchers target two oncogenes, potentially leading to therapies for melanoma, lung cancer, and other tumors
Additional ongoing funding would help the medical school expand enrollment
UC Riverside research is supported by a four-year grant worth more than $1.2 million
UC Riverside-led study is the first to show how tofacitinib affects epithelial cells lining the gut
UC Riverside-led study tested the effects of microgravity on intestinal epithelial cells
UC Riverside mouse study finds early exposure to sounds can address hypersensitivity to noise associated with Fragile X Syndrome
The shape and architecture of collagen and elastin fibers can improve our understanding of lung diseases, including the one associated with vaping
UC Riverside-led research could aid regenerative stem cell therapies
UC Riverside-led open-label pilot study leads to a double-blind clinical trial to further test ecopipam’s efficacy and safety in adult patients who stutter
Five-year, $16 million grant from the National Institutes of Health will help launch Center for Health Disparities Research at UC Riverside
Research is supported by a five-year grant to UC Riverside from the National Institutes of Health
UC Riverside-led mouse study focuses on cannabis-like molecules that augment feeding behavior
School of Medicine’s Nicholas DiPatrizio will lead a team tasked with assessing the impact of long-term cannabis exposure on metabolic health and disease
Medical school graduate Hurnan Vongsachang will start her residency in emergency medicine this summer
UC Riverside biomedical scientist’s decades-long work moves to clinical trials
Project is the first major effort in the UC system to assess the needs of students in recovery
Surgery is associated with increased survival for patients with HER2-positive stage 4 breast cancer
38 students in Class of 2019 were matched for a residency program of their choice
Research could help reduce females’ susceptibility to several diseases, such as Fragile X and Rett syndromes
Multiple sclerosis is an autoimmune disease that affects more than 2.3 million people worldwide. This debilitating condition periodically shutters communication between the brain and other parts of the body, resulting in symptoms that range from numbness and tingling in the arms and legs to blindness and paralysis. While treatments are...
